Sign inGet started

Clifton R. LaDuane

Insider CIK 1488774 · KMPH VP Fin & Corp Controller · LGL Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZVRA ZEVRA THERAPEUTICS, INC. M Exercise deriv2025-12-312026-01-0720,000— $00SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. M Exercise deriv2025-12-312026-01-0734,000— $00SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. M Exercise deriv2025-12-312026-01-0786,667— $00SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. M Exercise2025-12-312026-01-07140,667— $0192,028SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. F Tax w/h2025-12-312026-01-0748,513$8.96 $434.7K143,515SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. S Sale2025-02-132025-02-1411,000$7.86 $86.5K51,361SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. M Exercise deriv2025-01-312025-02-0343,333— $086,667SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. M Exercise2025-01-312025-02-0343,333— $062,361SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. A Award deriv2025-01-302025-02-0334,000— $034,000SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. A Award deriv2025-01-302025-02-0368,000— $068,000SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. P Buy2024-07-172024-07-172,000$6.77 $13.5K18,469SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. A Award deriv2024-01-312024-02-02130,000— $0130,000SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. P Buy2023-09-062023-09-061,000$4.96 $5.0K15,309SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. P Buy2023-05-182023-05-18689$4.95 $3.4K13,742SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. P Buy2023-05-182023-05-1851$4.94 $25211,053SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. P Buy2023-05-182023-05-182,000$4.95 $9.9K13,053SEC↗
ZVRA ZEVRA THERAPEUTICS, INC. P Buy2023-03-102023-03-131,725$4.15 $7.2K11,002SEC↗
KMPH KEMPHARM, INC P Buy2023-01-132023-01-1325$5.59 $1409,277SEC↗
KMPH KEMPHARM, INC P Buy2023-01-132023-01-13610$5.82 $3.6K9,252SEC↗
KMPH KEMPHARM, INC A Award deriv2023-01-092023-01-11459,726— $0459,726SEC↗
KMPH KEMPHARM, INC P Buy2022-09-302022-10-03600$5.98 $3.6K7,709SEC↗
KMPH KEMPHARM, INC P Buy2022-09-302022-10-03400$5.98 $2.4K8,109SEC↗
KMPH KEMPHARM, INC P Buy2022-05-182022-05-181,200$5.00 $6.0K6,440SEC↗
KMPH KEMPHARM, INC A Award deriv2022-02-012022-02-0383,486— $083,486SEC↗
KMPH KEMPHARM, INC P Buy2021-11-182021-11-18510$8.29 $4.2K5,240SEC↗
KMPH KEMPHARM, INC P Buy2021-09-292021-09-29215$9.38 $2.0K4,730SEC↗
KMPH KEMPHARM, INC P Buy2021-09-202021-09-20935$8.59 $8.0K4,515SEC↗
KMPH KEMPHARM, INC P Buy2021-09-012021-09-01230$9.11 $2.1K3,580SEC↗
KMPH KEMPHARM, INC A Award deriv2021-08-202021-08-2482,423— $082,423SEC↗
KMPH KEMPHARM, INC P Buy2021-06-232021-06-2475$14.11 $1.1K3,350SEC↗
KMPH KEMPHARM, INC P Buy2021-05-272021-05-27150$9.85 $1.5K3,275SEC↗
KMPH KEMPHARM, INC P Buy2020-08-262020-08-261,000$0.84 $84050,000SEC↗
KMPH KEMPHARM, INC P Buy2020-08-182020-08-182,000$0.70 $1.4K49,000SEC↗
KMPH KEMPHARM, INC P Buy2020-06-112020-06-111,500$0.19 $28547,000SEC↗
KMPH KEMPHARM, INC P Buy2020-05-262020-05-2611,500$0.18 $2.1K45,500SEC↗
KMPH KEMPHARM, INC P Buy2020-03-252020-03-251,000$0.22 $22034,000SEC↗
KMPH KEMPHARM, INC P Buy2020-03-112020-03-128,000$0.25 $2.0K33,000SEC↗
KMPH KEMPHARM, INC A Award deriv2020-02-052020-02-07160,000— $0160,000SEC↗
KMPH KEMPHARM, INC P Buy2019-12-272019-12-305,000$0.42 $2.1K22,750SEC↗
KMPH KEMPHARM, INC P Buy2019-12-272019-12-302,250$0.42 $94525,000SEC↗
KMPH KEMPHARM, INC P Buy2019-12-272019-12-305,000$0.42 $2.1K17,750SEC↗
KMPH KEMPHARM, INC A Award deriv2019-11-252019-11-2736,000— $036,000SEC↗
KMPH KEMPHARM, INC P Buy2019-09-252019-09-253,650$0.75 $2.7K12,750SEC↗
KMPH KEMPHARM, INC P Buy2019-09-162019-09-164,900$0.89 $4.4K9,100SEC↗
KMPH KEMPHARM, INC P Buy2019-09-162019-09-16100$0.86 $864,200SEC↗
KMPH KEMPHARM, INC P Buy2019-09-112019-09-11500$0.95 $4754,100SEC↗
KMPH KEMPHARM, INC P Buy2019-09-062019-09-06850$0.77 $6553,600SEC↗
KMPH KEMPHARM, INC A Award deriv2019-02-062019-02-08160,000— $0160,000SEC↗
KMPH KEMPHARM, INC P Buy2018-10-112018-10-11650$2.54 $1.7K2,750SEC↗
KMPH KEMPHARM, INC P Buy2018-05-312018-06-01525$6.10 $3.2K2,100SEC↗
KMPH KEMPHARM, INC A Award deriv2018-01-252018-01-2975,000— $075,000SEC↗
KMPH KEMPHARM, INC P Buy2017-09-252017-09-25300$3.78 $1.1K1,575SEC↗
KMPH KEMPHARM, INC P Buy2017-06-192017-06-21275$3.30 $9081,275SEC↗
KMPH KEMPHARM, INC P Buy2017-03-242017-03-27900$4.24 $3.8K900SEC↗
KMPH KEMPHARM, INC P Buy2017-03-242017-03-27100$4.24 $4241,000SEC↗
KMPH KEMPHARM, INC A Award deriv2017-01-272017-01-3175,000— $075,000SEC↗
KMPH KEMPHARM, INC A Award deriv2016-02-112016-02-1650,000— $050,000SEC↗
KMPH KEMPHARM, INC A Award deriv2015-09-042015-09-0915,000— $015,000SEC↗
KMPH KEMPHARM, INC A Award deriv2015-06-252015-06-2645,000— $045,000SEC↗
KMPH KEMPHARM, INC A Award deriv2015-04-152015-04-1721,333— $021,333SEC↗
LGL LGL GROUP INC A Award deriv2014-03-132014-03-172,339— $02,339SEC↗
LGL LGL GROUP INC A Award deriv2014-03-132014-03-186,589— $06,589SEC↗
LGL LGL GROUP INC J Other deriv2013-08-062013-08-0837,175— $037,175SEC↗
LGL LGL GROUP INC A Award deriv2013-03-262013-03-284,800— $04,800SEC↗
LGL LGL GROUP INC A Award2013-03-262013-03-282,229— $07,435SEC↗
LGL LGL GROUP INC A Award deriv2012-08-092012-08-1315,000— $015,000SEC↗
LGL LGL GROUP INC A Award2012-02-292012-03-051,600— $05,206SEC↗